Novel Imaging Approach Detects Tumors Earlier
Researchers at Barrow Neurological Institute (St. Joseph’s Hospital) and the Montreal Neurological Institute recently carried out a pilot study which suggests that a certain type of MRI scanning can proactively detect whether a patient is failing brain tumor treatment. It assesses the response before symptoms appear. Patients with recurring malignant brain tumors received scans through an imaging device known as MR spectroscopy. This device identifies metabolic changes. The study concluded that the use of metabolic imaging can identify chemical changes earlier than the technology of structural imaging such as CT scan or a conventional MRI. This imaging can be done frequently. It is non-invasive and poses no radiation hazards.
